Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 97

1.

Frequency of Evidence-Based Screening for Retinopathy in Type 1 Diabetes.

DCCT/EDIC Research Group, Nathan DM, Bebu I, Hainsworth D, Klein R, Tamborlane W, Lorenzi G, Gubitosi-Klug R, Lachin JM.

N Engl J Med. 2017 Apr 20;376(16):1507-1516. doi: 10.1056/NEJMoa1612836.

PMID:
28423305
2.

Epigenomic profiling reveals an association between persistence of DNA methylation and metabolic memory in the DCCT/EDIC type 1 diabetes cohort.

Chen Z, Miao F, Paterson AD, Lachin JM, Zhang L, Schones DE, Wu X, Wang J, Tompkins JD, Genuth S, Braffett BH, Riggs AD; DCCT/EDIC Research Group, Natarajan R.

Proc Natl Acad Sci U S A. 2016 May 24;113(21):E3002-11. doi: 10.1073/pnas.1603712113. Epub 2016 May 9.

3.

Glycemic Control and Urinary Tract Infections in Women with Type 1 Diabetes: Results from the DCCT/EDIC.

Lenherr SM, Clemens JQ, Braffett BH, Cleary PA, Dunn RL, Hotaling JM, Jacobson AM, Kim C, Herman W, Brown JS, Wessells H, Sarma AV; DCCT/EDIC Research Group.

J Urol. 2016 Oct;196(4):1129-35. doi: 10.1016/j.juro.2016.04.071. Epub 2016 Apr 27.

4.

Diabetic Central Neuropathy: CNS Damage Related to Hyperglycemia.

Malone JI.

Diabetes. 2016 Feb;65(2):355-7. doi: 10.2337/dbi15-0034. No abstract available.

5.

Caffeine Consumption Contributes to Skin Intrinsic Fluorescence in Type 1 Diabetes.

Eny KM, Orchard TJ, Miller RG, Maynard J, Grant DM, Costacou T, Cleary PA, Braffett BH, Paterson AD; DCCT/EDIC Research Group.

Diabetes Technol Ther. 2015 Oct;17(10):726-34. doi: 10.1089/dia.2015.0017. Epub 2015 Jul 20.

6.

Intensive diabetes therapy and ocular surgery in type 1 diabetes.

DCCT/EDIC Research Group, Aiello LP, Sun W, Das A, Gangaputra S, Kiss S, Klein R, Cleary PA, Lachin JM, Nathan DM.

N Engl J Med. 2015 Apr 30;372(18):1722-33. doi: 10.1056/NEJMoa1409463.

7.

The development and utility of a novel scale that quantifies the glycemic progression toward type 1 diabetes over 6 months.

Sosenko JM, Skyler JS, Beam CA, Boulware D, Mahon JL, Krischer JP, Greenbaum CJ, Rafkin LE, Matheson D, Herold KC, Palmer JP; Type 1 Diabetes TrialNet and Diabetes Prevention Trial–Type 1 Study Groups.

Diabetes Care. 2015 May;38(5):940-2. doi: 10.2337/dc14-2787. Epub 2015 Mar 10.

8.

A new approach for diagnosing type 1 diabetes in autoantibody-positive individuals based on prediction and natural history.

Sosenko JM, Skyler JS, DiMeglio LA, Beam CA, Krischer JP, Greenbaum CJ, Boulware D, Rafkin LE, Matheson D, Herold KC, Mahon J, Palmer JP; Type 1 Diabetes TrialNet Study Group; Diabetes Prevention Trial-Type 1 Study Group.

Diabetes Care. 2015 Feb;38(2):271-6. doi: 10.2337/dc14-1813. Epub 2014 Dec 17.

9.

Acceleration of the loss of the first-phase insulin response during the progression to type 1 diabetes in diabetes prevention trial-type 1 participants.

Sosenko JM, Skyler JS, Beam CA, Krischer JP, Greenbaum CJ, Mahon J, Rafkin LE, Matheson D, Herold KC, Palmer JP; Type 1 Diabetes TrialNet and Diabetes Prevention Trial–Type 1 Study Groups.

Diabetes. 2013 Dec;62(12):4179-83. doi: 10.2337/db13-0656. Epub 2013 Jul 17.

10.

The prediction of type 1 diabetes by multiple autoantibody levels and their incorporation into an autoantibody risk score in relatives of type 1 diabetic patients.

Sosenko JM, Skyler JS, Palmer JP, Krischer JP, Yu L, Mahon J, Beam CA, Boulware DC, Rafkin L, Schatz D, Eisenbarth G; Type 1 Diabetes TrialNet Study Group; Diabetes Prevention Trial-Type 1 Study Group.

Diabetes Care. 2013 Sep;36(9):2615-20. doi: 10.2337/dc13-0425. Epub 2013 Jul 1.

11.

Problems with the new born screen for galactosaemia.

Malone JI, Diaz-Thomas A, Swan K.

BMJ Case Rep. 2011 Jun 3;2011. pii: bcr0120113769. doi: 10.1136/bcr.01.2011.3769.

12.

Tetrahydrobiopterin therapy for phenylketonuria in infants and young children.

Burton BK, Adams DJ, Grange DK, Malone JI, Jurecki E, Bausell H, Marra KD, Sprietsma L, Swan KT.

J Pediatr. 2011 Mar;158(3):410-5. doi: 10.1016/j.jpeds.2010.08.016.

PMID:
20884009
13.

Microneedle-based automated therapy for diabetes mellitus.

Khanna P, Strom JA, Malone JI, Bhansali S.

J Diabetes Sci Technol. 2008 Nov;2(6):1122-9.

14.

Effect of a brief, regular telephone intervention by paraprofessionals for type 2 diabetes.

Sacco WP, Malone JI, Morrison AD, Friedman A, Wells K.

J Behav Med. 2009 Aug;32(4):349-59. doi: 10.1007/s10865-009-9209-4. Epub 2009 Apr 14.

PMID:
19365719
15.

Comparison of glycemic variability associated with insulin glargine and intermediate-acting insulin when used as the basal component of multiple daily injections for adolescents with type 1 diabetes.

White NH, Chase HP, Arslanian S, Tamborlane WV; 4030 Study Group.

Diabetes Care. 2009 Mar;32(3):387-93. doi: 10.2337/dc08-0800. Epub 2008 Dec 23.

16.

Hyperglycemia not hypoglycemia alters neuronal dendrites and impairs spatial memory.

Malone JI, Hanna S, Saporta S, Mervis RF, Park CR, Chong L, Diamond DM.

Pediatr Diabetes. 2008 Dec;9(6):531-9. doi: 10.1111/j.1399-5448.2008.00431.x.

PMID:
19067891
17.

Diabetes-induced bradycardia is an intrinsic metabolic defect reversed by carnitine.

Malone MA, Schocken DD, Hanna SK, Liang X, Malone JI.

Metabolism. 2007 Aug;56(8):1118-23.

PMID:
17618959
18.

Hyperglycemic brain injury in the rat.

Malone JI, Hanna SK, Saporta S.

Brain Res. 2006 Mar 3;1076(1):9-15. Epub 2006 Feb 17.

PMID:
16487498
19.

Cardio-protective effects of carnitine in streptozotocin-induced diabetic rats.

Malone JI, Cuthbertson DD, Malone MA, Schocken DD.

Cardiovasc Diabetol. 2006 Jan 19;5:2.

20.

Issues and advances in childhood diabetes.

Malone JI.

Adv Pediatr. 2004;51:111-29. Review. No abstract available.

PMID:
15366772

Supplemental Content

Loading ...
Support Center